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doi:10.1Background: A minimally invasive surgery for treatment of atrial fibrillation was developed with bilateral pul-
monary vein isolation, mapping, and ablation of the ganglionic plexi and excision of the left atrial appendage. A
prospective multicenter registry was created to evaluate the outcomes.
Methods: The procedure was performed through bilateral minithoracotomies with video assistance. It included
bilateral pulmonary vein isolation with bipolar radiofrequency with documentation of conduction block, location
of ganglionic plexi by high-frequency stimulation, and appropriate ablation and left atrial appendage exclusion/
excision. Clinical follow-up at 6 months included monitoring with electrocardiogram, Holter, event monitor, or
pacemaker interrogation.
Results: One hundred fourteen patients with 60 (52.6%) paroxysmal, 32 (28.1%) persistent, and 22 (19.3%)
long-standing persistent atrial fibrillations were treated. The mean age was 59.5  10.6 years, and 69.3%
were men. The mean follow-up period was 204  41 days (median 195). There were 2 (1.8%) operative mortal-
ities. At 6-month follow-up, with long-term monitoring, 52/60 (86.7%) patients with paroxysmal fibrillations
were in normal sinus rhythm and 43/60 (71.7%) were both in normal sinus rhythm and off antiarrhythmic drugs.
The patients with persistent atrial fibrillation had a lower success rate, with 18/32 (56.3%) being in normal sinus
rhythm and 46.9% both in normal sinus rhythm and off antiarrhythmic drugs; for long-standing persistent cases,
11/22 (50%) were in normal sinus rhythm and 7/22 (31.9%) were also off antiarrhythmic drugs.
Conclusions:Minimally invasive atrial fibrillation surgery is an effective treatment of paroxysmal atrial fibrilla-
tion at 6 months. Continuous event monitoring is necessary to accurately assess treatment results. A more exten-
sive lesion set seems to be required for treatment of persistent atrial fibrillation.E
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SThe pathophysiology of atrial fibrillations (AF) involves the
interplay between triggers and a changing left atrial substrate.
A complex network of interconnecting nerves (the intrinsic
cardiac autonomic nervous system) joins the left atrium to
the pulmonary veins (PVs). The neurons join in clusters of au-
tonomic ganglia in fat pads overlying the junction of the PVs
and the left atrium.1,2 These clusters are referred to as gangli-
onated plexi (GP) by Armour and colleagues.2 In 1987, Fee
and associates3 found that blocking the atrial fat pad ganglia
produced chronotropic, inotropic, and dromotropic changes
in the atria. Pappone and coworkers4 showed that long-term
success in maintaining sinus rhythm was correlated with the
presence of a vagal response during radiofrequency ablation
and attenuation of heart rate variability during subsequent fol-
low-up.Elimination of theGP in the caninemodel prevents in-
ducibility of AF.5 Additionally, there is clinical evidence fore Cardiopulmonary Research Science and Technology Institute,a Dallas, Tex;
cal City Dallas Hospital,b Dallas, Tex; St Francis Heart Center,c Indianapolis,
ashington Adventist Hospital,d Tacoma Park, Md; Oregon Heart and Vascu-
stitute,e Eugene, Ore; and University Community Hospital,f Tampa, Fla.
d for publication May 14, 2008; revisions received Aug 22, 2008; accepted for
cation Sept 19, 2008.
for reprints: James R. Edgerton, MD, 4708 Alliance Blvd, Suite 700, Plano,
s 75093 (E-mail: edgertonjr@aol.com).
c Cardiovasc Surg 2009;138:109-14
23/$36.00
ht  2009 by The American Association for Thoracic Surgery
016/j.jtcvs.2008.09.080
The Journal of Thoracic and Casuccessful elimination of AF by ablating areas of the auto-
nomic ganglia, suggesting that ganglia play a critical role in
the initiation andmaintenance ofAF.4,6-9 Scherlag and his col-
leagues6 have shown increased efficacy in the elimination of
AF by adding GP ablation to PV isolation in humans. Addi-
tionally, they have begun to study the elimination ofAFby ab-
lation of GP alone without PV electrical isolation.
Based on the above findings, we began performing a stan-
dardized procedure for the minimally invasive surgical treat-
ment of AF consisting of bilateral PV antral electrical
isolation and targeted autonomic denervation of the left
atrium with selective left atrial appendectomy. The feasibil-
ity of minimally invasive PV isolation has been previously
described.10-14 This study included 5 centers and their
patients.
PATIENTS AND METHODS
The study was approved by the institutional review board at each partici-
pating center and individual consents were obtained. One hundred seventy-
one patients underwent bilateral PV antral electrical isolation using a bipolar
radiofrequency clamp. A subset of 114 (66.7%) had complete 6-month fol-
low-up data including electrocardiogram (ECG), long-termmonitoring, and
antiarrhythmic drug usage data. This group included 60 cases of paroxysmal
(52.6%), 32 of persistent (28.1%), and 22 of long-standing persistent
(19.3%). Patients were grouped using the terminology recommended in
‘‘HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical
Ablation of Atrial Fibrillation,’’15 in which paroxysmal refers to recurrent
AF that terminates spontaneously within 7 days; persistent AF is AFrdiovascular Surgery c Volume 138, Number 1 109
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AF ¼ atrial fibrillations
ECG ¼ electrocardiogram
GP ¼ ganglionated plexi
LTM ¼ long-term monitor
NSR ¼ normal sinus rhythm
PV ¼ pulmonary veinsustained beyond 7 days, or lasting less than 7 days but requiring either
pharmacologic or electrical cardioversion; and long-standing persistent
AF is continuous AF of greater than 1-year duration.
All patients underwent transesophageal echocardiography on the table
prior to the procedure, and those who had a prior catheter ablation had
a left atrial magnetic resonance imaging or left atrial computed tomography
scan to rule out pulmonary vein stenosis. The procedure was accomplished
in 2 stages. With the patient in a left lateral decubitus position, the right-
sided PVs were approached through a small thoracotomy in the right chest,
and the patient then was repositioned and redraped in the right lateral decu-
bitus position to approach the left PVs through a limited left thoracotomy.
This thoracotomy, used to introduce instruments, was a 5.0-cm to 6.0-cm
incision in the third or fourth intercostal space without rib spreading. Visu-
alization was accomplished with a 5.0-mm 30 endoscope placed in the
middle to posterior axillary line in the sixth or seventh intercostal space.
The pericardium was opened widely, 2.0 cm anterior to the phrenic
nerve, with great caution to protect the phrenic nerve. Pericardial retraction
sutures were brought out through the posterior chest wall to aid in visuali-
zation. The PVs were mapped by first sensing in the PV to determine base-
line electrical activity. Then ganglionated plexi were located by high-
frequency stimulation of 12 V at a cycle length of 50 ms and a pulse width
of 1 to 10 ms.6 The presence of a GP was confirmed if a vagal response (in-
crease in the R-R interval of 50% or greater) occurred. After dissecting
around the PVs, a bipolar radiofrequency device was introduced and placed
around the PV antrum well up onto the left atrium, as far as possible away
from the PV bifurcation. Three to five ablation lines were placed in slightly
different positions to ensure electrical isolation. Following this, sensing was
repeated on the PVs to confirm entrance block from the left atrium indicat-
ing electrical isolation. The ablation was repeated as necessary until block
was demonstrated. High-frequency burst pacing was again done in areas
where GP were initially identified. If any vagal responses remained, these
areas were further locally ablated until the response to high-frequency stim-
ulation was considered negative as defined by no significant increase in the
R-to-R interval during stimulation.
A 19-French silastic drain was placed through the scope site, the working
port incisions were closed, the wounds dressed, and the patient was then po-
sitioned in the right lateral decubitus position to approach the left-sided PVs.
Similar exposure was obtained on the left side. On this side, the peri-
cardium was opened posterior to the phrenic nerve, thus aiding in visual-
ization of the PVs, the ligament of Marshall, and the base of the left atrial
appendage. Again, baseline mapping was done on the PVs as well as high-
frequency stimulation for localization of GP. Electrical isolation of the left
PV antrum was accomplished again with a bipolar radiofrequency clamp
after identifying and dividing the ligament of Marshall. Electrical block
was again confirmed by sensing for entrance block in the PVs. High-fre-
quency stimulation was repeated to ensure that there were no remaining
GP as measured by a vagal response during high-frequency stimulation.
The trabeculated portion of the left atrial appendage was then excised
or excluded using a stapling device, the pericardium closed, drain placed,
and the wounds were closed and dressed. The patient was then awakened,
extubated in the operating room, and transferred to the intensive care unit
for observational care.0 The Journal of Thoracic and Cardiovascular SurgRhythm Monitoring
Rhythmwasmonitored at the 6-month office visit. At 6months, all patients
had an ECG, and 1 long-termmonitor (LTM), either a 14- to 21-day auto-trig-
gered event monitor or 24-hour Holter monitor. Patients with implanted pace-
makers had the pacemaker interrogated for recorded episodes of AF. The
LTMs sampled the incoming rhythm at 15-second intervals, and if an irregular
rhythm was detected, a single 15-second rhythm sample was recorded. An-
other rhythm sequence was not recorded during that episode. Accordingly,
we counted the number of episodes of AF but were unable to determine the
duration of episodes over 15 seconds or the true burden of AF. Five patients
who displayed AF on the ECG monitoring were not hooked up to a LTM,
thus reducing costs when no new information would be provided.
Data Analysis
Data were imported into SAS 9.2 for analysis. Categorical variables were
compared across categories using chi-square or Fisher exact test, and con-
tinuous variables were compared across groups using analysis of variance
and Tukey post hoc testing if the differences were statistically significant.
All P values are 2-tailed tests.RESULTS
Demographics
Patient demographics are presented in Table 1. The age at
surgery, ejection fraction, and follow-up period were not dif-
ferent between groups. The patients had a history of long-
duration AF with 88.5% (10/113) reporting a history of
more than 1 year and a further 6.2% (7/113) reporting 6 to
12 months of AF. Twenty-four (21.1%) had had an unsuc-
cessful previous catheter ablation. In 92.7% of the patients
(101/109), the surgeon either amputated or sealed off the
left atrial appendage.
The mean length of stay from surgery to discharge was 4.8
 1.9 days with a median value of 4.0 days.Morbidity and Mortality
There were 13 complications among the 114 patients
(11.4%) undergoing ablation, as listed in Table 2. Two pa-
tients diedwithin the 30-day perioperative period: 1 very early
in the surgeon’s experience from hemorrhage resulting from
an avulsed left atrial appendage and 1 from unknown (incon-
clusive autopsy) cause. The latter patient was sent to recovery
after the surgery in normal sinus rhythm (NSR). The patient
was responsive and conversing with the nursing staff when
he complained of feeling nauseous. The patient went into re-
spiratory arrest, developed bradycardia as he was being intu-
bated, and then was transferred back to the operating room.
The patient was reexplored, and at that time, he went into car-
diopulmonary arrest, cardiogenic shock, and ventricular fibril-
lation.After defibrillation, the left ventriclewas observed to be
hypokinetic. No hemorrhage was found, and the pulmonary
veins looked intact. A saphenous vein graft to the left anterior
descending coronary arterywas carried out, and an intra-aortic
balloon pump placed. The patient left the operating room for
the intensive care unit and later in a decision with the family,
support was discontinued. A third patient died 51/2 months
after the ablation procedure from colon cancer.ery c July 2009
TABLE 1. Demographics
All patients Paroxysmal (n ¼ 60) Persistent (n ¼ 32)
Long-standing
persistent (n ¼ 22) P value*
Age, mean  standard
deviation (median)
59.5  10.6 (60.5) 59.7  8.2 (60) 59.7  10.6 (61.5) 58.3  15.6 (60.5) .86
Ejection fraction,%
(median)
54.2  9.5 (55.0) 54.8  10.3 (57) 53.3  8.8 (55) 53.7  8.4 (55) .79
Follow-up, d (median) 204  41 (195) 201  32 (195) 211  50 (198) 200  49 (197) .49
Males, n (%) 79 (69.3%) 40 (66.7%) 25 (78.1%) 14 (63.6%) .43
LA diameter, cm (median) 4.72  0.83 (4.6) 4.59  0.67 (4.5) 4.70  1.10 (4.5) 5.06  0.67 (4.95) .10
LA, Left atrium. *P value for continuous variables is analysis of variance comparing 3 groups (paroxysmal, persistent, and long-standing persistent); P value for the categorical
variable ‘‘males’’ is the chi-square for distribution of males across groups.
TABLE 3. Patient rhythm and AAD status at 6 months after ablation
Paroxysmal Persistent
Long-
standing
persistent P value
ECG NSR
Patients in
NSR
98.3% (59/60) 81.3% (26/32) 63.6% (14/22) <.001
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Complete rhythm documentation was available for
the 114 patients at 6 months with ECG and LTM data.
Long-term monitoring consisted of 24-hour Holter monitors
in 22.8% (26/114) of the patients, 14- to 21-day event mon-
itors in 59.7% (68/114), and pacemaker interrogations in
13.2% (15/114). A further 5 patients had AF picked up on
the ECG and were coded as AF for the long-term monitoring
also.
Table 3 show the rhythm results measured on ECG and
LTM for patients treated by the surgical ablation. Because
the strict definition of successful treatment requires that the
patient has regained anNSR rhythm and also been able to dis-
continue any antiarrhythmic drugs, the table also shows the
numbers reaching those goals. However, it should be noted
that the decision to terminate antiarrhythmic drugs was often
delayed until after the 6-month monitor was obtained.
Figures 1 and 2 graphs the fraction of patients with NSR
on ECG and LTM rhythm analysis and compares these with
the patient’s perception of their rhythm. In patients who
were diagnosed with paroxysmal AF before ablation,
86.7% (52/60) were in sinus rhythm at 6 months by LTM.
ECG measurements overestimated the fraction in sinus
rhythm, with 98.3% (59/60) being having ECG strips read
as NSR. For patients classified as having persistent or
long-standing persistent AF before surgery, the success
rate at 6 months by LTM was worse than paroxysmal:
56.3% in persistent and 50.0% in long-standing persistent.
The data from ECG measurements also overestimated the
success rate by approximately 25% percentage points for
persistent and 13.6% for long-standing persistent.
Because patients with NSR sometimes think that they are
in AF,16-20 we examined the data to see how accurate theirTABLE 2. Minor complications encountered in study
Transient nerve injury: 1.8% (2) 1 brachial plexus & 1 phrenic nerve
Renal failure: 1.8% (2) Without dialysis
Pulmonary problems: 4.4% (5) 5 temporary respiratory distress
Pericarditis: 0.9% (1)
Cardiac rhythm problems: 1.8% (2) 2 VFib
Coagulation problem: 0.9% (1)
VFib, Ventricular fibrillation.
The Journal of Thoracic and Caperceptions were. Data on patient perception was available
on 105 patients (53/60 paroxysmal, 30/32 persistent, and 22/
22 long-standing persistent). Based on their perception, only
3.8% (2/53) of the paroxysmal patients thought they were
still in AF, whereas by LTM, 7 (13.3%) were actually in
AF. Among patients with persistent or long-standing persis-
tent AF preoperatively, patient perception of postoperative
rhythm was even more unreliable, with few patients being
able to reliably determine that they were still in AF.Role of Left Atrium Diameter
To address the question of whether a larger left atrium di-
ameter increases the probability of failure rate for ablation,
logistic regression was run with the LTM 6-month outcome
as dependent variable. Neither left atrium diameter as a con-
tinuous variable or categorical (5 cm vs>5 cm) was a sta-
tistically significant predictor of AF at 6 months, after
controlling for the type of AF prior to ablation.
There was, however, a trend (P ¼ .10) toward a larger
mean left atrium diameter across the groups from paroxys-
mal to long-standing persistent (Table 1). When the diameter
was categorized above and below 5 cm, 36.4% (8/22) of
long-standing persistent patients had diameters of>5 cm,
whereas in the paroxysmal group, only 18.3% (11/60) had
diameters that large.Also off
AAD
80% (48/60) 68.8% (22/32) 36.4% (8/22) <.001
LTM NSR
Patients in
NSR
86.7% (52/60) 56.3% (18/32) 50.0% (11/22) <.001
Also off
AAD
71.7% (43/60) 46.9% (15/32) 31.8% (7/22) .002
AAD, Antiarrhythmic drugs; ECG, electrocardiogram; NSR, normal sinus rhythm;
LTM, long-term monitor.
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FIGURE 1. Outcomes for patients with paroxysmal atrial fibrillations (AF) as measured by electrocardiogram (ECG) and long-term monitor (LTM) along
with patient perception. NSR, Normal sinus rhythm.
E
T
/B
S
Evolving Technology/Basic Science Edgerton et alComparison of ECG and LTM Outcomes
Using ECG to determine the outcome after ablation may or
may not be accurate, depending on the circumstances. Because
ECG represents a shortwindow (typically 30 seconds), its abil-
ity to match LTM will depend on the outcome itself. Patients
who no longer have AF will record NSR on both LTM and
ECG. However, the problem arises in the group still having
AF. Depending on whether the AF is sparse as might be
seen in paroxysmal or fairly regular, the detection accuracy
will fluctuate. The sensitivity of ECG (true AF detected in all
patients with AF) varies from 13% in paroxysmal to 43% in
persistent and 73% in long-standing persistent patients.
The results are shown graphically in Figure 3. For each
type of AF, the LTM is the gold standard. ECG in all cases
records NSR for patients with NSR on LTM; thus the spec-
ificity (recorded as NSR in those noted as NSR on LTM) isFIGURE 2. Outcomes for patients with persistent and long-standing persistent
term monitor (LTM) along with patient perception. NSR, Normal sinus rhythm.
112 The Journal of Thoracic and Cardiovascular Surg100% in all cases. The graph shows the ability to correctly
diagnose AF in patients who are known to still be having AF
from the LTM.
DISCUSSION
It has been shown previously21 that there is up to a 40% dif-
ference in detection rates of AF when comparing implanted
devices to random ECGs. Our data would confirm that the
true burden of AF is not accurately assessed by random sam-
plings of rhythmmonitoring such as randomECGs.Neverthe-
less, most published literature today, prior to the HRS/EHRA/
ECASExpert Consensus Statement, does use interval random
ECGs or short rhythm strips to determine the outcomes of
treatment for AF. Previous literature also uses widely varying
criteria for ‘‘success.’’ We adhered strictly to the Consensus
Statement definitions and recommendations. In that context,atrial fibrillations (AF) as measured by electrocardiogram (ECG) and long-
ery c July 2009
FIGURE 3. The accuracy of electrocardiogram (ECG) in identifying pa-
tients known to still be in atrial fibrillations (AF). Patients are initially iden-
tified as in AF by long-term monitor. NSR, Normal sinus rhythm.
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very favorably. Had we used only ECG to assess the success
of surgery onpatientswith persistent and long-standing persis-
tent AF (as many previous studies have done), treatment
would have been deemed highly efficacious with a success
rate of 81.5%. However, true success rates for persistent and
long-standing persistent AF of 56.5% by longer-term moni-
toring leave room for improvement.
It is not too surprising that PV antral isolation and partial
autonomic denervation would not be adequate treatment
for a patient in persistent and long-standing persistent AF be-
cause of the associated changes in the left atrial substrate that
occur in these conditions.22 Electrical remodeling of the left
atrium results in a fixed shortened refractory period and
a shortened fibrillatory interval.23 Atrial fibrosis has also
been associated with AF.24 Therefore, isolating the PV trig-
gers alone is likely inadequate treatment for persistent and
long-standing persistent AF. A more extensive lesion set
similar to the left-sided Cox Maze-III may be necessary.
It is widely recognized that increasing left atrial size cor-
relates with a lower success rate for ablation. That our data
did not confirm this is surprising and may relate to the rela-
tively small sample size.
Evidence-baseddata support bothPVelectrical isolation and
targeted partial autonomic denervation in the treatment of AF.
These techniques can be combined in aminimally invasive sur-
gical approach. Early data suggest that this is an efficacious ap-
proach to the treatment of paroxysmal AF. Further studies are
needed to firmly establish the safety of the procedure. Longer-
termmonitoring is essential to determine the trueburden ofAF.
Minimally invasive techniques using a more extensive lesion
set are beingdeveloped for the surgical treatment of long-stand-
ing persistent AF from an epicardial approach.
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Dr T. Nitta (Tokyo, Japan). First, I would like to praise the au-
thors for presenting the data in a manner that strictly adheres to the
consensus statement published in the Heart Rhythm Journal last
year. Based on the statement, the major points we should follow
when reporting are the patient follow-up protocol, definition of suc-
cess for AF ablation, and assessment of postoperative cardiac
rhythm. If one would like to have surgical outcomes compared to
those of catheter ablation, the data must be reported in the same for-
mat based on an identical protocol.
The most striking message in this work was that there was a sig-
nificant difference in the detection rates ofAF between randomly re-
corded ECG and long-term rhythm monitoring. The true burden of
AF was not accurately assessed by random samplings of rhythm
monitoring from the regular ECG. I feel that we should reexamine
our patients using the long-termmonitoringmethods, such as Holter
monitoring and the event recorder, and reevaluate the outcomes af-
ter surgery. I have 2 questions for the authors of this excellent work.
First, how many patients actually had GP ablation? As I read
your manuscript, you first mapped the GP, performed PV isolation,
and then performed high-frequency burst pacing again to test the
vagal response. Local GP ablation was performed only in the pa-
tients who showed remaining vagal responses after PV isolation.
Given that you did not perform the GP ablation in all patients, I
would like to know the impact of the GP ablation on the success
rate of AF, and if there was any correlation between the location
of GP ablation and success rate for each type of AF.
The second question is about the future of minimally invasive
AF surgery. PV isolation alone or with GP ablation may not be
an adequate treatment for persistent and long-standing persistent
AF. Recent reports on catheter-based AF ablation have shown114 The Journal of Thoracic and Cardiovascular Surgthat additional linear ablation or ablation of fractionated electro-
grams improves the success rate. As long as the lesion set is the
same, catheter-based ablation will always be less invasive than sur-
gical ablation. Do you think surgery should also move in the same
direction, or should we return to the maze procedure as a way of
dealing with advances of catheter-based ablation in the treatment
of persistent or long-standing persistent AF?
Thank you for the privilege of discussing this work.
Dr Edgerton (Dallas, Tex). Thank you for your comments.
With respect to the Chair, I will try to be brief.
I fear that perhaps we miscommunicated in the manuscript, and I
will make sure that that is cleared up. All these patients were done
identically at the 5 centers because we wanted to know that the re-
sults were translatable. Everyone had GP ablation. GPs were map-
ped before the ablation, the isolation of the pulmonary veins, then
we went back and mapped for any surviving GPs and ablated all of
those. So they were all done identically. I can’t tell you the impact,
therefore, of GP ablation.
To your second point, I refer back to Dr Turina’s excellent lec-
ture yesterday that showed when the arterial switch operation was
begun, the mortality was 50%, yet he didn’t give up, and we have
learned from this andmoved on.We have designed now a technique
to perform, through a minimally invasive approach, the full left
atrial lesion set that Dr Cox designed for the maze III. I have 20 pa-
tients who have 6-month long-term monitoring. I am presenting
that tomorrow at the Heart Rhythm Society. So we have moved
on to now perform the full left-sided maze lesion set. For patients
with long-standing AF, the results are significantly improved
over what we presented here, and although there were only small
numbers of patients, we think the early results are promising.
Thank you for your comments.ery c July 2009
